The Tumor Vaccine Group at the University of Washington is a multidisciplinary group of investigators focused on the diagnosis, prevention and treatment of cancer with novel, immune-based approaches. Involving scientists, doctors, nurses, and patients, our translational research works to bring the most innovative treatments from the bench to the bedside and to harmonize scientific study with patient care.
In the News:
- A Vaccine May Aid Colon Cancer Prevention in the Future
- Cancer Cure Inc.
- UW cancer expert to be editor-in-chief of new JAMA journal